180 Life Sciences CORP 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
180 Life Sciences Corp. files an amendment to its annual report on Form 10-K to include required XBRL tagging for certain disclosures.
180 Life Sciences Corp. files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted disclosures regarding directors, executive compensation, security ownership, related transactions, and principal accountant fees.
180 Life Sciences Corp. reports its annual results, highlighting a strategic shift towards the iGaming industry with the acquisition of a blockchain casino platform, while addressing ongoing financial challenges and legacy biotechnology programs.
180 Life Sciences Corp. has filed an amendment to its annual report to include previously omitted disclosures regarding directors, executive compensation, and related matters.
180 Life Sciences Corp., a clinical-stage biotech company, released its 2023 annual report, highlighting ongoing research and development efforts amidst financial constraints and a strategic review process.